Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2017 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Recent advances in atezolizumab-based programmed death-ligand 1 (PD-L1) blockade therapy for breast cancer.
Int Immunopharmacol. 2022 Dec;113(Pt A):109334. doi: 10.1016/j.intimp.2022.109334. Epub 2022 Oct 31.
Int Immunopharmacol. 2022.
PMID: 36327869
Review.
Combination therapy with nivolumab (anti-PD-1 monoclonal antibody): A new era in tumor immunotherapy.
Abedi Kiasari B, Abbasi A, Ghasemi Darestani N, Adabi N, Moradian A, Yazdani Y, Sadat Hosseini G, Gholami N, Janati S.
Abedi Kiasari B, et al.
Int Immunopharmacol. 2022 Dec;113(Pt A):109365. doi: 10.1016/j.intimp.2022.109365. Epub 2022 Nov 1.
Int Immunopharmacol. 2022.
PMID: 36332452
Review.
Item in Clipboard
Asymptomatic Herpes Simplex Virus Infection in Iranian Mothers and Their Newborns.
Tavakoli A, Monavari SH, Bokharaei-Salim F, Mollaei H, Abedi-Kiasari B, Fallah FH, Mortazavi HS.
Tavakoli A, et al. Among authors: abedi kiasari b.
Fetal Pediatr Pathol. 2017 Feb;36(1):27-32. doi: 10.1080/15513815.2016.1229368. Epub 2016 Oct 20.
Fetal Pediatr Pathol. 2017.
PMID: 27762667
Item in Clipboard
Cite
Cite